PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced it has granted stock options to purchase 30,000 shares of common stock to a newly hired employee as part of an inducement to join the company.
The non-qualified stock options were issued outside of the company’s 2021 Long-Term Performance Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted on October 1, 2025, with an exercise price of $0.97 per share, equal to the closing price of Context’s stock on the grant date.
The options carry a 10-year term and will vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining shares vesting in equal monthly installments over the following three years, contingent on continued employment with Context.
The grant underscores the company’s use of equity awards to attract and retain talent as it advances its clinical and business objectives.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.